论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
七氟醚麻醉与异丙酚麻醉对活体肾移植供者术后早期肾功能影响的随机对照试验
Authors Cai J, Kang F , Han M , Huang X, Yan W, Wan F, Li J
Received 11 July 2024
Accepted for publication 14 January 2025
Published 23 January 2025 Volume 2025:19 Pages 491—503
DOI https://doi.org/10.2147/DDDT.S486393
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Prof. Dr. Georgios Panos
Jianyue Cai,1,* Fang Kang,1,* Mingming Han,1 Xiang Huang,1 Wenlong Yan,1 Fuzhen Wan,2,3 Juan Li1
1Department of Anesthesiology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, People’s Republic of China; 2Department of Gastrointestinal Surgery, The second Affiliated Hospital of Anhui Medical University, Hefei, People’s Republic of China; 3Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia
*These authors contributed equally to this work
Correspondence: Juan Li, Administrative Director, Department of Anesthesia, First Affiliated Hospital of the University of Science and Technology of China, Tel +8613956005465, Email huamuzi1999@163.com
Purpose: Living kidney transplantation is a common treatment for end-stage renal disease. The impact of anaesthetics on postoperative biomarkers of renal injury in living kidney transplant donors is not well understood.
Patients and Methods: 70 transplant donors who underwent kidney extraction were randomly assigned to following two groups: sevoflurane (S group) and propofol (P group). Urine and blood were collected before induction and 1, 2, 6 days after operation. Kidney injury marker-1 (KIM-1), interleukin-18 (IL-18) and tissue inhibitor of metalloproteinase-2 (TIMP-2) were measured by enzyme-linked immunosorbent assay. Record the cystatin C, glomerular filtration rate, urine output during perioperative period.
Results: There were both increases in biomarkers of kidney injury before and 1, 2 and 6 days after the anaesthetic surgery in donors, However, no statistical differences in KIM-1 (P (0.42 pg/mL (95% CI 0.21 to 0.63 pg/mL)) vs S (0.26 pg/mL (95% CI 0.02 to 0.49 pg/mL)), − 0.16 pg/mL (95% CI − 0.48 to 0.16 pg/mL)), IL-18 (P (178.54 pg/mL (95% CI 110.15 to 24693 pg/mL)) vs S (175.86 pg/mL (95% CI 100.35 to 251.38 pg/mL)), − 2.68 pg/mL (95% CI − 105.61 to 100.25 pg/mL)), and TIMP-2 (P (12.88 ng/mL (95% CI 8.69 to 17.07 ng/mL)) vs S (14.85 ng/mL (95% CI 10.23 to 19.46 ng/mL)), 1.97 ng/mL (95% CI − 4.30 to 8.23 ng/mL)) concentration changes between the two types of anaesthesia.
Conclusion: There was no difference between sevoflurane and propofol anaesthesia on postoperative changes in biomarkers of renal injury in living kidney transplant donors.
Keywords: general anesthetics, sevoflurane, propofol, renal transplantation